NCT00728052 - A Human Volunteer Study Investigating Single Oral Doses of GSK598809 in Otherwise Healthy Smokers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 9, 2008

Primary Completion Date

August 19, 2008

Study Completion Date

August 19, 2008

Conditions

Substance Dependence

Interventions

DRUG

GSK598809

GSK598809 capsules will be available with dose strengths of 5 milligrams and 25 milligrams, administered orally with water.

DRUG

Placebo

Placebo capsules will be administered orally with water.

Trial Locations (1)

GSK Investigational Site, Berlin